NEW YORK – Researchers from Ambry genetics and Mayo Clinic last month soft-launched an interactive mutation prevalence tool aimed at helping clinicians identify appropriate testing for their cancer patients.
Ambry Genetics, Mayo Clinic Develop Mutation Prevalence Tool to Guide Docs on Appropriate Testing
Premium
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.